Kernodle Clinic, Inc. — Burlington, North Carolina

Kernodle Clinic, Inc. is a clinical research site located in Burlington, North Carolina, United States 27215.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Kernodle Clinic, Inc. has participated in 5 clinical trials.

Therapeutic areas: Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease.

Sponsors: Cogentus Pharmaceuticals, Pfizer, Novartis.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kernodle Clinic, Inc.?

Kernodle Clinic, Inc. has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kernodle Clinic, Inc. conducted?

Kernodle Clinic, Inc. has 5 clinical trials on record. Their work covers Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease.

Is Kernodle Clinic, Inc. accredited by Crixeo Health?

Yes — Kernodle Clinic, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kernodle Clinic, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.